[Federal Register Volume 87, Number 97 (Thursday, May 19, 2022)]
[Notices]
[Page 30448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10746]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-19-2022]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification 
of Proposed Production Activity, AbbVie Ltd., (Pharmaceutical 
Products), Barceloneta, Puerto Rico

    AbbVie Ltd., submitted a notification of proposed production 
activity to the FTZ Board (the Board) for its facility in Barceloneta, 
Puerto Rico within Subzone 7I. The notification conforming to the 
requirements of the Board's regulations (15 CFR 400.22) was received on 
May 13, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material and specific finished 
product described in the submitted notification (summarized below) and 
subsequently authorized by the Board. The benefits that may stem from 
conducting production activity under FTZ procedures are explained in 
the background section of the Board's website--accessible via 
www.trade.gov/ftz. The proposed finished product and material would be 
added to the production authority that the Board previously approved 
for the operation, as reflected on the Board's website.
    The proposed finished product is venetoclax film coated tablets 
(duty-free).
    The proposed foreign-status material is venetoclax active 
pharmaceutical ingredient (duty rate 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is June 28, 2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: May 13, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-10746 Filed 5-18-22; 8:45 am]
BILLING CODE 3510-DS-P